Azithromycin and Pregnancy: Risks, Benefits & Safety Information
Azithromycin (a macrolide) treats community‑acquired pneumonia, chlamydia, and other infections. In pregnancy, it is FDA Category B (animal studies show no risk; human data limited but reassuring).
Potential Concerns
- Cardiac Effects: Prolongs QT interval; caution with other QT‑prolonging drugs or congenital long QT syndrome.
- Infantile Hypertrophic Pyloric Stenosis (IHPS): Some studies associate macrolide use in first 2 weeks of life (or late pregnancy) with IHPS; absolute risk low.
- Hepatotoxicity: Rare; monitor if pre‑existing liver disease.
Clinical Decision
Benefits of treating a significant infection (chlamydia, pneumonia) usually outweigh theoretical risks. Untreated infections pose greater fetal/maternal danger. Always discuss with your obstetrician—alternative antibiotics (penicillins, cephalosporins) may be preferred for certain indications.
Do not self‑medicate; take exactly as prescribed; complete the course.
Pregnancy & Health - Related Articles
- Truffles During Pregnancy & Breastfeeding: Safety Guidelines
- Understanding Childbirth Methods: A Comprehensive Guide
- Recurrent Chromosomal Abnormalities in Pregnancy: Risk Assessment & Counseling
- Cramping and Spotting at 15 Weeks Pregnant: What It Could Mean
- Understanding Abortion Options & Accessing Safe Care
- Gas and Constipation in Pregnancy: Causes and Management
- Susten 400mg in Pregnancy: Clarification on Nonexistent Product
